Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia

J Bertherat, I Bourdeau, L Bouys… - Endocrine …, 2023 - academic.oup.com
Patients with primary bilateral macronodular adrenal hyperplasia (PBMAH) usually present
bilateral benign adrenocortical macronodules at imaging and variable levels of cortisol …

Expanding the role of the histone lysine-specific demethylase LSD1 in cancer

B Majello, F Gorini, CD Saccà, S Amente - Cancers, 2019 - mdpi.com
Studies of alterations in histone methylation in cancer have led to the identification of histone
methyltransferases and demethylases as novel targets for therapy. Lysine-specific …

Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016

AJ Cowan, C Allen, A Barac, H Basaleem… - JAMA …, 2018 - jamanetwork.com
Introduction Multiple myeloma (MM) is a plasma cell neoplasm with substantial morbidity
and mortality. A comprehensive description of the global burden of MM is needed to help …

Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study

F Chasseloup, I Bourdeau, A Tabarin… - The lancet Diabetes & …, 2021 - thelancet.com
Background GIP-dependent primary bilateral macronodular adrenal hyperplasia with
Cushing's syndrome is caused by aberrant expression of the GIP receptor in adrenal …

Organoids as innovative models for bone and Joint diseases

J Huang, L Zhang, A Lu, C Liang - Cells, 2023 - mdpi.com
Bone is one of the key components of the musculoskeletal system. Bone and joint disease
are the fourth most widespread disease, in addition to cardiovascular disease, cancer, and …

Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease

IP Cavalcante, A Berthon, MC Fragoso… - Nature Reviews …, 2022 - nature.com
Primary bilateral macronodular adrenal hyperplasia (PBMAH) is an adrenal cause of
Cushing syndrome. Nowadays, a PBMAH diagnosis is more frequent than previously, as a …

Epidemiology, genetics and treatment of multiple myeloma and precursor diseases

K Hemminki, A Försti, R Houlston… - International journal of …, 2021 - Wiley Online Library
Multiple myeloma (MM) is a hematological malignancy caused by the clonal expansion of
plasma cells. The incidence of MM worldwide is increasing with greater than 140 000 …

Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk

A Sud, S Chattopadhyay, H Thomsen… - Blood, The Journal …, 2019 - ashpublications.org
Estimating familial cancer risks is clinically important in being able to discriminate between
individuals in the population at differing risk for malignancy. To gain insight into the familial …

KDM1A inactivation causes hereditary food-dependent Cushing syndrome

A Vaczlavik, L Bouys, F Violon, G Giannone… - Genetics in …, 2022 - Elsevier
Purpose This study aimed to investigate the genetic cause of food-dependent Cushing
syndrome (FDCS) observed in patients with primary bilateral macronodular adrenal …

Genome instability in multiple myeloma: Facts and factors

AY Aksenova, AS Zhuk, AG Lada, IV Zotova… - Cancers, 2021 - mdpi.com
Simple Summary Multiple myeloma is an incurable blood cancer caused by the malignant
transformation of immunoglobulin-producing plasma cells. The mechanisms leading to the …